NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I think some of these could drop any time and not necessarily after approval. In fact, it makes sense if they want to hedge their bets, to get some of these additional trials going before final decisions on applications. We already know the vaccine has a powerful impact so there is no reason to delay.

I also think they should hold out to be compensated for such a trial and not be giving DCVax-L away at a discount, it should benefit shareholders as we’ve paid to get to this point ourselves with no help from BP.

We’ll see if that deal can be negotiated prior to approval.